Abstract
Purpose. To study the effect of particle size, air flow and inhaler type on the dispersion of spray dried mannitol powders into aerosols.
Methods. Mannitol powders were prepared by spray drying. The solid state properties of the powders were determined by laser diffraction, X-ray powder diffraction, scanning electron microscopy, freeze fracture, Karl Fischer titration and gas pycnometry. The powders were dispersed using Rotahaler® and Dinkihaler®, connected to a multistage liquid impinger at different air flows.
Results. Three crystalline mannitol powders with primary particle size (MMD) 2.7, 5.0, 7.3 μm and a similar polydispersity were obtained. The particles were spherical with a density of 1.5 g/cm3 and a moisture content of 0.4 wt.%. At an air flow of 30 L/min all the powders were poorly dispersed by both inhalers. With the Rotahaler® increasing the flow (60−120 L/min) increased the fine particle fraction (FPF) in the aerosols for the 2.7 μm powder, and decreased the FPF for the 7.3 μm powder; whereas the FPF for 5.0 μm powder was unaffected. With the Dinkihaler®, all the powders were near complete dispersion at ≥60 L/min.
Conclusions. The FPF in the mannitol powder aerosols was determined by an interplay of the particle size, air flow and inhaler design.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
E. M. Philips, M. T. Carvajal, and M. M. Munroe. Characterizing variable amorphous content in powders for inhalation. In R. N. Dalby, P. N. Byron, S. J. Farr (eds.), Respiratory Drug Delivery V, Interpharm Press Inc., Baffalo Grove, IL, 253–260 (1996).
H.-K. Chan, A. Clark, I. Gonda, M. Mumenthaler, and C. Hsu. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. 14:431–437 (1997).
S. D. Anderson, J. Brannan, J. Spring, N. Spalding, L. T. Rodwell, H.-K. Chan, I. Gonda, A. M. Walsh, and A. R. Clark. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am. J. Respir. Crit. Care Med. 156:758–765 (1997).
E. Daviskas, S. D. Anderson, J. D. Brannan, H.-K. Chan, S. Eberl, and G. Bautovich. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur. Respir. J. 10:2449–2454 (1997).
M. A. Braun, R. Oschmann, and P. C. Schmidt. Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the twin impinger. Int. J. Pharm. 135:53–62 (1996).
P. Zanen, P. I. van Spiegel, H. van der Kolk, E. Tushuizen, and R. Enthoven. The effect of the inhalation flow on the performance of a dry powder inhalation system. Int. J. Pharm. 81:199–203 (1992).
A. H. de Boer, D. Gjaltema, and P. Hagedoorn. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2: Effect of peak flow rate (PIER) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int. J. Pharm. 138:45–56 (1996).
D. L. French, D. A. Edwards, and R. W. Niven. The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J. Aerosol Sci. 27:769–783 (1996).
V. A. Philip, R. C. Mehta, and P. P. Deluca. In vitro and in vivo respirable fractions of isopropanol treated PLGA microspheres using a dry powder inhaler. Int. J. Pharm. 151:175–182 (1997).
A. R. Clark and A. M. Hollingworth. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers—Implications for in vitro testing. J. Aerosol Med 6:99–110 (1993).
D. M. Mitchell, M. A. Solomon, S. E. J. Tolfree, M. Short, and S. G. Spiro. Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax. 42:457–461 (1987).
M. M. Clay, D. Pavia, and S. W. Clarke. Effect of aerosol particle size on bronchodilation with nebulised terbutaline in asthmatic subjects. Thorax. 41:364–368 (1986).
D. Ganderton and N. M. Kassem. Dry powder inhalers. In: D. Ganderton, T. Jones (eds.), Advances in Pharmaceutical Sciences, Academic Press London, 1992, 165–191.
B. W. Low and F. M. Richards. The use of the gradient tube for the determination of crystal densities. J. Am. Chem. Soc. 74:1660–66 (1952).
H.-K. Chan and I. Gonda. Solid state characterization of spray-dried powders of recombinant human deoxyribonuclease (RhDNase). J. Pharm. Sci. 87:647–654. (1998).
L. Asking and B. Olsson. Calibration at different flow rates of a multistage liquid impinger. Aerosol Sci. Tech. 27:39–49 (1997).
S. Budavari. The Merck Index: an encyclopedia of chemicals, drugs, and biologicals, Merck & Co. Inc., Whitehouse Station, NJ, 1996, pp. 979.
A. Wade and P. J. Weller. Handbook of Pharmaceutical Excipients. Pharmaceutical Press, London, 1994, pp. 294–298.
I. Gonda, Phyisco-chemical principles in aerosol delivery, In D. J. A. Crommelin and K. K. Midha (eds.), Topics in Pharmaceutical Sciences 1991, Medpharm Sci. Publ, Stuttgart, 1992, Ch. 7, pp. 95–115.
N. A. Fuchs. The Mechanics of Aerosols, Pergamon Press, Oxford, 1964, pp. 353–377.
A. D. Zimon. Adhesion of Dust and Powder, Plenum Press, New York, 1969, pp. 22–36.
K. J. Smith, H.-K. Chan, and K. F. Brown. Influence of flow rate on aerosol particle size distributions from pressurised and breath-actuated inhalers. J. Aerosol Med 11:231–245 (1998).
J. Visser. Particle adhesion and removal: a review. Particulate Sci. Technol. 13:169–196 (1995).
M. Soltani and G. Ahmadi. On particle adhesion and removal mechanisms in turbulent flows. J. Adhesion Sci. Technol. 8:763–785 (1994).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chew, N.Y.K., Chan, HK. Influence of Particle Size, Air Flow, and Inhaler Device on the Dispersion of Mannitol Powders as Aerosols. Pharm Res 16, 1098–1103 (1999). https://doi.org/10.1023/A:1018952203687
Issue Date:
DOI: https://doi.org/10.1023/A:1018952203687